Total Payments
$3.1M
2024 Payments
$104,065
Companies
26
Transactions
724
Payment Breakdown by Category
Other$2.5M (79.3%)
Consulting$603,602 (19.4%)
Travel$26,319 (0.8%)
Food & Beverage$12,346 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $2.2M | 1 | 70.6% |
| Consulting Fee | $603,602 | 150 | 19.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $249,221 | 14 | 8.0% |
| Travel and Lodging | $26,319 | 265 | 0.8% |
| Honoraria | $22,219 | 9 | 0.7% |
| Food and Beverage | $12,346 | 285 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kadmon Corporation LLC | $2.4M | 28 | $0 (2021) |
| Medimetriks Pharmaceuticals, Inc. | $153,202 | 26 | $0 (2019) |
| DERMIRA, INC. | $118,602 | 41 | $0 (2020) |
| LEO Pharma Inc. | $111,731 | 23 | $0 (2024) |
| LEO Pharma AS | $59,313 | 111 | $0 (2024) |
| ABBVIE INC. | $52,595 | 114 | $0 (2024) |
| UCB SA | $24,556 | 29 | $0 (2024) |
| PFIZER INC. | $22,661 | 18 | $0 (2024) |
| Amgen Inc. | $22,478 | 71 | $0 (2024) |
| Incyte Corporation | $21,269 | 61 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104,065 | 127 | LEO Pharma Inc. ($56,334) |
| 2023 | $63,907 | 110 | UCB SA ($18,886) |
| 2022 | $34,508 | 65 | LEO Pharma Inc. ($17,670) |
| 2021 | $2.4M | 23 | Kadmon Corporation LLC ($2.3M) |
| 2020 | $166,315 | 36 | Kadmon Corporation LLC ($80,904) |
| 2019 | $175,000 | 129 | DERMIRA, INC. ($84,898) |
| 2018 | $97,696 | 110 | Medimetriks Pharmaceuticals, Inc. ($59,400) |
| 2017 | $106,512 | 124 | Medimetriks Pharmaceuticals, Inc. ($83,002) |
All Payment Transactions
724 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | LEO Pharma AS | — | Consulting Fee | Cash or cash equivalent | $6,335.00 | General |
| 11/04/2024 | Amgen Inc. | Enbrel (Biological) | Consulting Fee | Cash or cash equivalent | $3,484.87 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,301.02 | General |
| 11/04/2024 | LEO Pharma AS | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,853.00 | General |
| 11/04/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,481.28 | General |
| 11/04/2024 | Amgen Inc. | Enbrel (Biological) | Travel and Lodging | Cash or cash equivalent | $750.60 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $711.00 | General |
| 11/04/2024 | LEO Pharma AS | — | Travel and Lodging | Cash or cash equivalent | $399.15 | General |
| 11/04/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $319.05 | General |
| 11/04/2024 | Amgen Inc. | Enbrel (Biological) | Travel and Lodging | Cash or cash equivalent | $68.84 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $65.21 | General |
| 11/04/2024 | LEO Pharma AS | — | Travel and Lodging | Cash or cash equivalent | $36.61 | General |
| 11/04/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $29.26 | General |
| 10/30/2024 | LEO Pharma AS | — | Consulting Fee | Cash or cash equivalent | $4,525.00 | General |
| 10/09/2024 | LEO Pharma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,560.00 | General |
| 09/28/2024 | Amgen Inc. | Enbrel (Biological) | Travel and Lodging | In-kind items and services | $82.55 | General |
| Category: Inflammation | ||||||
| 09/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.02 | General |
| 09/28/2024 | LEO Pharma AS | — | Travel and Lodging | Cash or cash equivalent | $39.31 | General |
| 09/28/2024 | Amgen Inc. | Enbrel (Biological) | Travel and Lodging | In-kind items and services | $32.60 | General |
| Category: Inflammation | ||||||
| 09/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.65 | General |
| 09/28/2024 | LEO Pharma AS | — | Travel and Lodging | Cash or cash equivalent | $15.52 | General |
| 09/28/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $13.86 | General |
| 09/28/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Inflammation | ||||||
| 09/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $5.85 | General |
| 09/28/2024 | LEO Pharma AS | — | Food and Beverage | Cash or cash equivalent | $3.28 | General |
About Dr. David Cohen, M.D
Dr. David Cohen, M.D is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730179680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cohen, M.D has received a total of $3.1M in payments from pharmaceutical and medical device companies, with $104,065 received in 2024. These payments were reported across 724 transactions from 26 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($2.2M).
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 10/24/2005
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1730179680
Products in Payments
- QBREXZA (Drug) $33,704
- Enbrel (Biological) $22,478
- Sumadan Wash (Drug) $14,400
- COSENTYX (Biological) $13,544
- TREMFYA (Drug) $12,177
- ADBRY (Biological) $11,672
- Otezla (Drug) $6,613
- Bimzelx (Biological) $4,974
- NO PRODUCT DISCUSSED (Drug) $2,930
- Cimzia (Drug) $2,909
- ALTRENO (Drug) $2,860
- TALTZ (Drug) $2,554
- Tremfya (Drug) $2,430
- STELARA (Biological) $1,531
- VTAMA (Drug) $422.79
- OPZELURA (Drug) $263.22
- JANUVIA (Drug) $124.25
- LEVULAN KERASTICK (Drug) $109.67
- FASENRA (Biological) $108.07
- Zoryve (Drug) $71.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M
Mr. Michael Cameron
Dermatology — Payments: $1.9M
Dermatology $1.9M